The Founder and CEO of Netmeds, Pradeep Dadha has a rich experience in pharmaceutical business. Pradeep started the online pharmacy marketplace in 2015 after seeing how other sectors such as grocery and lifestyle were performing in the field of e-commerce. The Netmeds CEO Pradeep used his acute business sense to widen the reach of its […]
Read More » Netmeds CEO – Pradeep Dadha
Daniel O’Day became chairman and CEO of the US-based biopharmaceutical company Gilead Sciences, Inc. in March 2019 after John Milligan’s resignation from the post. Gilead’s headquarters is in Foster City, California. He helped company sail through the COVID-19 turmoil and came up with the first approved antiviral Remdesivir. Since the time he joined this high-profile […]
Read More » Gilead CEO – Daniel O’Day (Age – 57)
David A. Ricks (also called Dave) joined the position of CEO and Chairman at the American medicine company, Eli Lilly and Company, in 2017 after John Lechleiter’s retirement. Eli Lilly CEO Dave Ricks has spent 22 years with the company, starting his career as Business Development Associate. He previously worked with IBM also for some […]
Read More » Eli Lilly CEO – Dave Ricks (Age – 54)
Richard A. (Rick) Gonzalez is CEO and Chairman of the leading American bio-pharmaceutical company, AbbVie, since 2013. Abbvie was spun off from Abbott Laboratories, which makes medical and diagnostic equipment and nutrition products. AbbVie CEO Richard Gonzalez is a pharma industry veteran with more than 30 years of experience. Today, he is heading a company […]
Read More » AbbVie CEO – Richard Gonzalez
After Kevin W. Sharer left, Robert A. (Bob) Bradway became the representative of California-based biopharmaceutical company, Amgen Inc., as CEO in 2012. He is also company’s Chairman since 2013 and a Board of Director since 2011. Amgen CEO Robert Bradway started his career with the company back in 2006 as VP of Operations Strategy. Prior […]
Read More » Amgen CEO – Robert Bradway (Age – 58)
After Richard Clark’s retirement, Kenneth Frazier took over the reins of American biopharmaceutical company Merck & Co. as CEO and Chairman. Merck, a pharmaceutical behemoth worldwide, was originally a subsidiary of Merck Group. But it became independent in 1917 and is known by the name Merck in the United States and Canada. Merck CEO Kenneth […]
Read More » Merck CEO – Kenneth Frazier
Steven Collis (Steven H. Collis or Steve Collis) became the President and CEO of one of America’s leading pharmaceutical sourcing and distribution company AmerisourceBergen Corporation in 2011 after the exit of R. David Yost. In 2016, he was also made the Chairman of the company. As AmerisourceBergen CEO, Steven has helped the company with exponential […]
Read More » AmerisourceBergen CEO – Steven Collis
David Wichmann (David Scott Wichmann) became the Chief Executive of the for-profit publicly listed healthcare company UnitedHealth Group in September 2017, after Stephen Hemsley left his position. UnitedHealth Group CEO David has been working with the company since 1998, holding senior positions at different divisions. His awareness about the global markets places him on a […]
Read More » UnitedHealth Group CEO – David Wichmann
In 2018, Michael Kaufmann replaced George Barrett to take charge of the role of CEO at one of the largest Ohio-based pharmaceutical and medical product distributors and publicly listed companies Cardinal Health Inc. Cardinal Health CEO Michael is best recognized for his strategies, financial analysis, gender diversity, general management, etc. He played a key role […]
Read More » Cardinal Health CEO – Michael Kaufmann
Tim Wentworth took the position of Chief Executive Officer in 2016 and President in 2014 at one of America’s Fortune 100 companies and a healthcare giant Express Scripts Holding Co, after the exit of George Paz. From strategy to core business, his responsibilities cover all the aspects of the company. Express Scripts CEO Tim led […]
Read More » Express Scripts CEO – Tim Wentworth